Schall, N., Talamini, L., Wilhelm, M., Jouvin-Marche, E. & Muller, S. (2022) P140 peptide leads to clearance of autoreactive lymphocytes and normalizes immune response in lupus-prone mice. Front. Immunol. 13:904669. doi

Retnakumar, S.V., Geesala, R., Bretin, A., Tourneur-Marsille, J., Ogier-Denis, E., Maretzky, T., Nguyen, H.T.T & Muller, S. (2022) Targeting the endo-lysosomal autophagy pathway to treat inflammatory bowel diseases. J. Autoimmunity 128:102814

Brun, S., De Sèze, J. & Muller, S. (2022). CIDP: Current treatments and identification of targets for future specific therapeutic intervention. Immuno 2, 118-131.

Srinivasa Reddy Bonam, Christine Tranchant and Sylviane Muller (2021). Autophagy-Lysosomal Pathway as Potential Therapeutic Target in Parkinson’s Disease . Cells 10, 3547.

Schall, N., Daubeuf, F., Marsol, C. Frossard, N., Bonnet D., Galzi, J.-L. Muller, S. (2021). A selective neutraligand for CXCL12/SDF-1a with beneficial regulatory functions in MRL/lpr lupus prone mice. Front Pharmacol 12, 752194.

Daubeuf F, Schall N, Petit-Demoulière N, Frossard N, Muller S (2021). An autophagy modulator peptide prevents lung function decrease and corrects established inflammation in murine models of airway allergy. Cells 10(9):2468. doi: 10.3390/cells10092468.

Rafiq S, McKenna SL, Muller S, Tschan MP, Humbert M (2021). Lysosomes in acute myeloid leukemia: potential therapeutic targets? Leukemia. doi: 10.1038/s41375-021-01388-x.

Wilhelm M, Bonam SR, Schall N, Bendorius M, Korganow AA, Lumbroso C, Muller S (2021). Implication of a lysosomal antigen in the pathogenesis of lupus erythematosus. J Autoimmunity 120:102633. doi: 10.1016/j.jaut.2021.102633.

Dotan A, Kanduc D, Muller S, Makatsariya A, Shoenfeld Y (2021). Molecular mimicry between SARS-CoV-2 and the female reproductive system. Am J Reprod Immunol 10.1111/aji.13494. doi: 10.1111/aji.13494.

Talamini L, Matsuura E, De Cola L, Muller S (2021). Immunologically inert nanostructures as selective therapeutic tools in inflammatory diseases. Cells 10(3):707. doi: 10.3390/cells10030707.

Dotan A, Muller S, Kanduc D, David P, Halpert G, Shoenfeld Y (2021). The SARS-CoV-2 as an instrumental trigger of autoimmunity. Autoimmunity Rev 20(4):102792. doi: 10.1016/j.autrev.2021.102792.

Klionsky DJ et al. (2021). Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy 8:1-382.

Bonam SR, Muller S (2020). Parkinson’s disease is an autoimmune disease: a reappraisal. Autoimmunity Rev 19(12):102684. doi: 10.1016/j.autrev.2020.102684.

Wang F, Tasset I, Cuervo AM, Muller S (2020). In vivo remodeling of altered autophagy-lysosomal pathway by a phosphopeptide in lupus. Cells 9(10):2328. doi: 10.3390/cells9102328.

Bonam SR, Muller S, Bayry J, Klionsky DJ (2020). Autophagy as an emerging target for COVID-19: lessons from an old friend, chloroquine. Autophagy 16(12):2260-2266. doi: 10.1080/15548627.2020.1779467.

Narasaraju T, Tang BM, Herrmann M, Muller S, Chow VTK, Radic M (2020). Neutrophilia and NETopathy as Key Pathologic Drivers of Progressive Lung Impairment in Patients With COVID-19. Frontiers in Pharmacology 11:870.

Voynova E, Lefebvre F, Qadri A, Muller S (2020). Correction of autophagy impairment inhibits pathology in the NOD.H-2h4 mouse model of primary Sjögren's syndrome. J of Autoimmunity 108:102418. doi: 10.1016/j.jaut.2020.102418

Bonam SR, Tschan MP, Bayry J, Muller S (2020). Progress and challenges in the use of MAP1LC3 as a legitimate marker for measuring dynamic autophagy in vivo. Cells 9(5):1321. doi: 10.3390/cells9051321.

Bonam SR, Areti A, Komirishetty P, Muller S (2020). Dendrimers in immunotherapy and hormone therapy in Pharmaceutical applications of dendrimers; chapter 10, pp 233-249. Abhay Chauhan and Hitesh Kulhari (Eds) Elsevier.

Bonam SR, Ruff M, Muller S (2019). HSPA8/HSC70 in Immune Disorders: A Molecular Rheostat that Adjusts Chaperone-Mediated Autophagy Substrates. Cells 8:849.

Retnakumar SV, Muller S (2019). Pharmacological Autophagy Regulators as Therapeutic Agents for Inflammatory Bowel Diseases. Trends Mol Med. 25:516-537.

Bonam SR, Bhunia D, Muller S, Nerella SG, Alvala M, Halmuthur Mahabalarao SK (2019). Novel trisaccharide based phospholipids as immunomodulators. Int Immunopharmacol 74:105684.

Bonam SR, Wang F, Muller S (2019). Lysosomes as a therapeutic target. Nat Rev Drug Discovery 18:923-948.

Arbogast F, Arnold J, Hammann P, Kuhn L, Chicher J, Murera D, Weishaar J, Muller S, Fauny JD, Gros F (2019). ATG5 is required for B cell polarization and presentation of particulate antigens. Autophagy 15:280-294.

Bendorius M, Po C, Muller S, Jeltsch-David H (2018). From systemic inflammation to neuroinflammation: the case of neurolupus. Int J Mol Sci 19:3588.

Bonam SR, Wang F, Muller S (2018). Autophagy: A new concept in autoimmunity regulation and a novel therapeutic option. Journal of Autoimmunity 94:16-32.

Bendorius M, Neeli I, Wang F, Bonam SR, Dombi E, Buron N, Borgne-Sanchez A, Poulton J, Radic M, Muller S (2018). The mitochondrion-lysosome axis in adaptive and innate immunity: Effect of lupus regulator peptide P140 on mitochondria autophagy and NETosis. Front Immunol 9:2158.

Bonam SR, Wu YS, Tunki L, Chellian R, Kumar Halmuthur MS, Muller S, and Pandy V (2018). What Has Come out from Phytomedicines and Herbal Edibles for the Treatment of Cancer? ChemMedChem 13:1854-1872.

Brun S, Schall N, Bonam SR, Bigauta K, Mensah-Nyagana AG, de Sèze J, Muller S (2018). An autophagy-targeting peptide to treat chronic inflammatory demyelinating polyneuropathies.

BERMÚDEZ, M., ARÉVALO-PINZÓN, G., RUBIO, L., CHALOIN, O., MULLER, S., CURTIDOR, H. & PATARROYO, M.A. (2018).Receptor-ligand and parasite protein-protein interactions in Plasmodium vivax: analysing rhoptry neck proteins 2 and 4. Cell. Microbiol. 20, e12835

KÖKTEN, T., GIBOT, S., LEPAGE, P., D’ALESSIO, S., HABLOT, J., NDIAYE, N.-C., BUSBY-VENNER, H., MONOT, C., GARNIER, B., MOULIN, D., JOUZEAU, J.-Y., HANSMANNEL, F., DANESE, S., GUÉANT, J.-L., MULLER, S. & PEYRIN-       BIROULET, L. (2018). TREM-1 inhibition restores impaired autophagy activity and reduces colitis in mice. J. Crohn Colitis 2018, 230-244

LI, B., WANG, F., SCHALL, N. & MULLER, S. (2018). Rescue of autophagy and lysosome defects in salivary glands of MRL/lpr mice by a therapeutic phosphopeptide. J. Autoimmunity 90, 132-145

MURERA, D., ARBOGAST, F., ARNOLD, J., BOUIS, D., MULLER, S. & GROS, F. (2018). CD4 T cell autophagy is integral to memory maintenance. Sci. Rep. 8, 5951

WANG, F., BONAM, S.R, SCHALL, N., KUHN, L., HAMMANN, P., CHALOIN, O., MADINIER, J.-B., BRIAND, J.-P., PAGE, N. & MULLER, S. (2018). Blocking nuclear export of HSPA8 after heat shock stress severely alters cell survival. Sci. Rep. 8, 16820

WILHELM, M., WANG, F., SCHALL, N., KLEINMANN, J.-F., FALUDI, M., NASHI, E.P., SIBILIA, J., MARTIN, T., SCHAEFFER, E. & MULLER, S. (2018). Lupus regulator peptide P140 represses B-cell antigen differentiation by reducing HLA class II overexpression. Arthritis Rheum 70, 1077-1088

MULLER, S. (2018). Excipients: not so inert? When the excipient plays the role of an active substance, as exemplified in systemic lupus. Swiss Med Wkly 148, w14631